14/08/2026
🫁 RSV Vaccination Programme Expansion from 1 September 2026
The NHS is expanding eligibility for the RSV (Respiratory Syncytial Virus) vaccine to help protect more people at risk of serious respiratory illness. From 1 September 2026, the vaccine will be available to:
✅ Adults aged 65 to 74 years with: • Chronic respiratory disease (including asthma, COPD, bronchiectasis, cystic fibrosis and other significant lung conditions)�• Immunosuppression due to disease or treatment
The RSV vaccine remains available for: ✅ Pregnant women from 28 weeks of pregnancy�✅ Adults aged 75 years and over�✅ Residents of care homes for older adults
RSV can cause serious lung infections, particularly in older adults and those with underlying health conditions. Vaccination helps reduce the risk of severe illness and hospital admission.
If you believe you may be eligible and have not heard from us, please contact the surgery.
Sources: NHS England and UKHSA guidance on the expansion of RSV vaccine eligibility from 1 September 2026. 12